title: Nivolumab (Opdivo) plus ipilimumab (Yervoy) for metastatic melanoma.
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D000074324:Ipilimumab; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary; D009154:Mutation; D000077594:Nivolumab; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics
chemical_list: D000911:Antibodies, Monoclonal; D000074324:Ipilimumab; D000077594:Nivolumab; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf